Kolexia
Gherga Elisabeta Radio-thérapie
Gherga Elisabeta
Radio-thérapie
Le Mittan Annexe Du Hnfc
Montbéliard, France
55 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Carcinomes Tumeurs du pancréas Tumeurs épidermoïdes Métastase tumorale Récidive tumorale locale Adénocarcinome

Collaborateurs

Voir plus
Sun Xu-Shan
Sun Xu-Shan
Le Mittan Annexe Du Hnfc, Montbéliard, France
Boulbair Fatiha
Boulbair Fatiha
Le Mittan Annexe Du Hnfc, Montbéliard, France
Kim Chong Hun
Kim Chong Hun
Hôpital Saint-Jacques de Besançon, Besançon, France
Mayer Joséphine
Mayer Joséphine
Hnfc Site Trevenans, Trévenans, France

Industries

Voir plus
Vifor
2 collaboration(s)
Dernière en 2021
B3TSI
2 collaboration(s)
Dernière en 2020
Amgen
2 collaboration(s)
Dernière en 2023
Ipsen
1 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
KS01.6.A UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
European journal of cancer (Oxford, England : 1990)   09 janvier 2023
Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial: A Phase I/II Randomized Study to Determine the Maximum Tolerated Dose, Safety, Pharmacokinetics and Antitumor Activity of Debio 1143 Combined With Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Essai Clinique (Debiopharm)   22 juin 2022
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   02 novembre 2020
FOLFOXIRI FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study.
World journal of gastrointestinal oncology   28 septembre 2020
914MO Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
The Lancet. Oncology   03 août 2020
FOLFOXIRI versus FOLFIRINOX in first-line chemotherapy in patients with advanced pancreatic cancer: A propensity score analysis
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain   01 octobre 2019
Radiothérapie hypofractionnée en split course de patients âgés et fragiles atteints d’un cancer de la tête et du cou localement évolué : étude de 58 cas
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   01 octobre 2018
PET-based prognostic survival model after radiotherapy for head and neck cancer.
European journal of nuclear medicine and molecular imaging   21 août 2018